This is the third and final post of a series (part 1 and part 2) on directed evolution. What do protein engineers actually produce using directed...

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...

Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...

Illumina recently announced the $1000 solution for the sequencing of the human genome in the form of its new instrument, the HiSeqX. This system...

The selection and accumulation of desirable mutations – also known as natural selection – has shaped the living world. The proteins resulting from...

One major challenge in drug discovery is determining whether a drug is behaving as intended, binding the “right” protein, inhibiting the correct...

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast amount...

Incretins are hormones that the body uses to stimulate insulin release when nutrients are ingested. The two that are the most well-studied are...

This is Part 2 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 3). Recent medical technology...

So how does the pharmaceutical industry restore its jaded public image? The answer is by changing itself from within, by paying more than just lip...